We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The Rs 620 crore deal gives RIL 60 per cent holding in equity capital of Vitalic and 100 per cent direct equity ownership of its subsidiaries — Tresara Health, Netmeds Market Place and Dadha Pharma Distribution.